Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia

NCT03822507 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

404

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism

Interventions

DRUG: KHK7580
DRUG: Cinacalcet Hydrochloride

Sponsor

Kyowa Kirin Co., Ltd.

Collaborators

[object Object]
[object Object]